A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE)

NCT03329638 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia

Interventions

DRUG: DE-127 Ophthalmic Solution low dose
DRUG: DE-127 Ophthalmic Solution medium dose
DRUG: DE-127 Ophthalmic Solution high dose
DRUG: Placebo Ophthalmic Solution

Sponsor

Santen Pharmaceutical Co., Ltd.